3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Condylomata Acuminata
2
Keratosis, Actinic
1
Interventions
3-ingenyl angelate
33
Imiquimod
18
Aminolevulinic Acid
16
Gels
10
Diclofenac
10
Photochemotherapy
7
methyl 5-aminolevulinate
6
Fluorouracil
6
Solutions
5
LEO 43204
5
BF-200 ALA
5
tirbanibulin
4
Ointments
4
Cryotherapy
3
SR-T100
2
potassium dobesilate
1
green tea extract polyphenone E
1
beta-solamarine
1
afamelanotide
1
Therapies, Investigational
1
Therapeutics
1
Petrolatum
1
Excipients
1
Drugs, Generic
1
Cryosurgery
1
Control Groups
1
AVX001
1
5-fluorouracil, salicylic acid drug combination
1
1-phenyl-3,3-dimethyltriazene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Keratosis, Actinic
×
green tea extract polyphenone E
×
Clear all
NCT07137819
2025-08-22
EXACT-1
Aresus Pharma GmbH
Phase 3
Recruiting
280 enrolled